Access to biotech research/reports without a Bloomberg terminal?

To dive into clinical-stage biotech investing without a Bloomberg terminal, here are some practical alternatives based on the most helpful WSO content:

1. Publicly Available Resources:

   • Use clinicaltrials.gov to track ongoing trials, their phases, and expected completion dates. This is a goldmine for understanding the trial landscape.
   • The FDA website provides updates on drug approvals, PDUFA dates, and other regulatory milestones.

2. Equity Research Reports:

   • Check your university library or alumni network for access to equity research reports. Many institutions have subscriptions to platforms like CapitalIQ or PitchBook.
   • Use Google with the search extension filetype:pdf to find publicly available reports. For example, search "biotech equity research filetype:pdf."

3. Networking:

   • Connect with junior equity research professionals on LinkedIn, especially those in the biotech space. Building relationships can sometimes lead to access to insights or reports.
   • Reach out to alumni in equity research or the buyside for guidance or resources.

4. Specialized Publications:

   • Subscribe to industry-specific publications like FierceBiotech or FiercePharma for updates on trials, partnerships, and catalysts.
   • Follow biotech-focused blogs and forums for community-driven insights.

5. Investor Presentations and SEC Filings:

   • Review investor presentations and SEC filings of the companies you're interested in. These often include timelines for trials, expected catalysts, and financial health.

6. Alternative Platforms:

   • Platforms like Seeking Alpha or StockTwits often have biotech-focused contributors who analyze upcoming catalysts.
   • Consider lower-cost subscription services that specialize in biotech investing.

7. Proactive Learning:

   • Compile your findings into a presentation or document to organize your research. This will help you stay on top of catalysts and make informed decisions.

By leveraging these resources and staying proactive, you can effectively navigate the biotech investing space without the hefty cost of a Bloomberg terminal.

Sources: How Do I Get Smart in Biotechnology Space?, Guide To Evaluate a Biotech Company, What's your Top Stock Pick for 2017